多发性硬化患者液体摄入与泌尿系统症状的关系
一项前瞻性横断面研究纳入200例多发性硬化患者,采用排尿日记和AUA症状评分评估液体摄入与下尿路症状。结果显示总液体摄入与症状严重程度无关,47%患者为控制症状而限制液体摄入,且限制液体者症状更重;咖啡因摄入对症状影响极小。
要点
- 多发性硬化患者日均总液体摄入2489ml,与下尿路症状严重程度无关。
- 47%患者报告为控制排尿症状而限制液体摄入,且此类患者症状更重。
- 咖啡因摄入与症状严重程度仅呈极小关联,总液体摄入无显著关联。
核心结论
- 多发性硬化患者平均总液体摄入量为2489ml(SD 1883),总液体摄入与下尿路症状严重程度无关。
- 咖啡因摄入对下尿路症状仅有极小影响(OR 1.00,95%CI 1.00-1.01,p=0.01)。
- 47%的患者报告通过限制液体摄入来控制泌尿症状,且限制液体者症状更重(OR 1.95,95%CI 1.53-2.47,p<0.01)。
研究设计与样本
- 前瞻性横断面研究,纳入200例就诊于神经内科门诊的多发性硬化患者。
- 液体摄入采用基于问卷的排尿日记评估,下尿路症状采用美国泌尿协会症状评分(AUA-SS)评估。
- 采用单因素和多因素分析评估液体摄入与下尿路症状的关系。
主要发现
- 日均总液体摄入量为2489ml(SD 1883),在不同下尿路症状严重程度(轻、中、重)间无差异(F=0.30,p=0.74)。
- 47%的患者报告有液体限制行为以控制泌尿症状。
- 限制液体摄入的患者更可能出现更严重的泌尿症状(OR 1.95,95%CI 1.53-2.47,p<0.01)。
- 多因素分析校正液体限制行为后,咖啡因摄入与下尿路症状严重程度仅有极小关联(OR 1.00,95%CI 1.00-1.01,p=0.01)。
- 总液体摄入与下尿路症状严重程度无关联(OR 1.00,95%CI 1.00-1.00,p=0.07)。
临床怎么用
- 多发性硬化患者平均并不存在过度水化,但相当比例患者为控制症状而限制液体摄入。
- 液体摄入可能并非多发性硬化患者下尿路症状的重要 contributing 因素,限制液体摄入或非必要。
- 咖啡因摄入对下尿路症状影响极小,无需过度强调限制咖啡因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The relationship between fluid intake and lower urinary tract symptoms in individuals with neurogenic bladder is unknown. We investigated the association between fluid intake and urinary symptoms in patients with multiple sclerosis. MATERIALS AND METHODS: A prospective cross-sectional study of patients with multiple sclerosis presenting to the neurology office was conducted. Fluid intake and lower urinary tract symptoms were assessed by the questionnaire based voiding diary and the American Urological Association Symptom Score, respectively. The relationship between fluid intake and lower urinary tract symptoms was assessed using univariate and multivariate analyses. RESULTS: Among 200 individuals with multiple sclerosis the mean total daily fluid intake was 2,489 ml (SD 1,883) and did not differ according to severity (ie mild, moderate, severe) of lower urinary tract symptoms (F=0.30, p=0.74). Fluid restricting behavior to control urinary symptoms was reported by 47% of subjects. Subjects who reported fluid restricting were more likely to have worse urinary symptoms (OR 1.95, 95% CI 1.53-2.47, p <0.01). After accounting for fluid restricting behavior on multivariate analysis, there was a minimal relationship between caffeinated fluid intake and lower urinary tract symptom severity (OR 1.00, 95% CI 1.00-1.01, p=0.01), and there was no relationship between total fluid intake and lower urinary tract symptom severity (OR 1.00, 95% CI 1.00-1.00, p=0.07). CONCLUSIONS: Caffeinated fluid intake has a minimal effect on lower urinary tract symptoms in patients with multiple sclerosis. On average, patients with multiple sclerosis do not hydrate excessively and a considerable proportion restrict fluid intake to control urinary symptoms. Fluid intake may not contribute considerably to lower urinary tract symptoms in patients with multiple sclerosis.
引用
- Tam J, Gross MD, Cheung A, et al. Fluid Intake and Urinary Symptoms in Patients with Multiple Sclerosis. J Urol. 2020. PMID: 32924823. doi:10.1097/JU.0000000000001309
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。